Companies › TCRT
ALAUNOS THERAPEUTICS INC (TCRT)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001107421 · EDGAR filings · Updated 2026-07-27
ALAUNOS THERAPEUTICS INC (TCRT) has reported institutional ownership of 5.3%, with 29 institutional managers holding positions valued at $360.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (4)
- 2026-07-27 — Insider transaction reported (Form 4)
- 2026-07-27 — Insider transaction reported (Form 4)
- 2026-07-27 — Insider transaction reported (Form 4)
- 2026-07-27 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-06 — Employee-plan registration (S-8) filed
- 2026-07-02 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ALAUNOS THERAPEUTICS INC has 29 institutional holders and institutional ownership of 5.3%.
Insider activity
Insiders reported 12 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
MUSTANG BIO INC (MBIO) · ACLARION INC (ACON) · Aspire Biopharma Holdings Inc (ASBP) · CNS PHARMACEUTICALS INC (CNSP) · MOLECULIN BIOTECH INC (MBRX) · KAIROS PHARMA LTD (KAPA)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.